Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03073525
Title Trial of Atezolizumab and Vigil for Advanced Gynecological Cancers (A Companion Study to CL-PTL-119)
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Gradalis, Inc.
Indications

female reproductive organ cancer

Therapies

Atezolizumab + FANG vaccine

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.